Comprehensive Biomarker Testing for Lung Cancer: Who Needs It & What’s It For?

Medically Reviewed

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles
6) Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated June 23rd, 2022

Comprehensive Biomarker Testing for Lung Cancer: Who Needs It & What’s It For?

Comprehensive biomarker testing is genetic testing of a lung tumor that tells doctors whether targeted therapy will work.

NOW
PLAYING
Beloved Florida First Lady Casey DeSantis, 42, Wife Of Governor Ron DeSantis, 43, Launches Digital Cancer Resource Initiative: Mom Of 3 Is Giving Back After Beating Cancer
NOW
PLAYING
Kathy Griffin, 61, Back At The Doctor For Infusion After Cancer Battle
NOW
PLAYING
Finally Some Progress For Esophageal Cancer Patients - New Immunotherapy Drugs Are Boosting Survival
NOW
PLAYING
Sherry Pollex, Longtime Love of NASCAR's Martin Truex Jr., Continues to 'Keep Faith' That There is Hope With Treatment For Her Ovarian Cancer
NOW
PLAYING
Your Diagnosis May Be Difficult But You Deserve Comfort and the Best Care - How Can Cancer Survivors Advocate For Themselves?
NOW
PLAYING
Von Hippel-Lindau: Epididymal Cystadenomas

Later Stage Treatment: The Importance of Biomarker Testing

SEE MORE   

  • Changes in cancer cells are called biomarkers and can affect treatment.
  • In lung cancer, there are two sets of biomarkers: driver mutations and PDL1.
  • Normal cells become cancer cells because of driver mutations. PDL1 on cancer cells stops your immune system from killing them.

Later Stage Treatment: The Importance of Biomarker Testing

  • Changes in cancer cells are called biomarkers and can affect treatment.
  • In lung cancer, there are two sets of biomarkers: driver mutations and PDL1.
  • Normal cells become cancer cells because of driver mutations. PDL1 on cancer cells stops your immune system from killing them.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.